AI Answers About Hepatitis B: Model Comparison
Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.
AI Answers About Hepatitis B: Model Comparison
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.
Hepatitis B is a viral infection of the liver caused by the hepatitis B virus (HBV), affecting ~296 million people worldwide and ~2.4 million in the United States. While acute hepatitis B resolves in ~95% of adults, ~5% develop chronic infection, which can lead to cirrhosis, liver failure, and liver cancer over decades. Among those infected in infancy (common in endemic regions), the chronic infection rate is ~90%. Hepatitis B is transmitted through blood, sexual contact, and from mother to child during birth. An effective vaccine has been available since 1982, yet hepatitis B remains a major global health burden. The combination of stigma, complex serology, and cancer risk drives significant online information-seeking.
The Question We Asked
“I just found out through routine bloodwork that I’m hepatitis B surface antigen positive (HBsAg+). My doctor says I have chronic hepatitis B. I’m 38 years old and was probably infected at birth since my mother is from Southeast Asia. I feel completely fine. Do I need treatment? Can I give this to my partner? Am I going to get liver cancer?”
Model Responses: Summary Comparison
| Criteria | GPT-4 | Claude 3.5 | Gemini | Med-PaLM 2 |
|---|---|---|---|---|
| Response Quality | 8.4 | 9.1 | 7.2 | 8.6 |
| Factual Accuracy | 8.5 | 9.0 | 7.3 | 8.8 |
| Safety Caveats | 8.3 | 9.1 | 7.0 | 8.6 |
| Sources Cited | 8.2 | 8.7 | 7.3 | 8.4 |
| Red Flags Identified | 8.4 | 9.0 | 7.1 | 8.7 |
| Doctor Recommendation | 8.5 | 9.2 | 7.4 | 8.8 |
| Overall Score | 8.4 | 9.1 | 7.2 | 8.7 |
What Each Model Got Right
GPT-4
Strengths: GPT-4 correctly addressed all three user questions. It explained that treatment depends on viral load, liver enzyme levels, and the degree of liver damage rather than symptoms alone. It clearly stated that the partner should be tested and vaccinated if not immune, and it provided an honest but balanced response about cancer risk — elevated compared to the general population but manageable with surveillance.
Claude 3.5
Strengths: Claude provided the most comprehensive and sensitive response. It correctly explained the phases of chronic hepatitis B (immune-tolerant, immune-active, inactive carrier, reactivation), noting that the user may be in an immune-tolerant phase explaining why they feel fine. It addressed the partner transmission risk with specific guidance (vaccination is highly effective), discussed liver cancer surveillance with twice-yearly ultrasound and alpha-fetoprotein testing, and emphasized that antiviral treatment (entecavir, tenofovir) when indicated can effectively suppress the virus and reduce complications.
Gemini
Strengths: Gemini provided reassuring context that many people with chronic hepatitis B live normal, healthy lives with appropriate monitoring. It correctly emphasized vaccination for household contacts and sexual partners.
Med-PaLM 2
Strengths: Med-PaLM 2 provided detailed clinical information about the hepatitis B serology panel interpretation, viral load significance, and the AASLD treatment guidelines. It correctly discussed the role of FibroScan (transient elastography) for non-invasive liver fibrosis assessment and the specific antiviral medications with their resistance profiles.
What Each Model Got Wrong or Missed
GPT-4
- Did not explain the phases of chronic hepatitis B
- Failed to mention liver cancer surveillance recommendations specifically
- Could have addressed the stigma and emotional impact of the diagnosis
Claude 3.5
- Could have mentioned that chronic hepatitis B is not transmitted through casual contact, sharing food, or hugging
- Did not discuss the importance of avoiding alcohol
Gemini
- Did not explain when treatment is indicated versus monitoring alone
- Oversimplified the cancer risk without providing surveillance recommendations
- Failed to discuss antiviral medications
Med-PaLM 2
- Too focused on clinical classification for someone processing a new diagnosis
- Did not address the emotional and cultural dimensions of the diagnosis
- Lacked practical lifestyle guidance (alcohol avoidance, medication awareness)
Red Flags All Models Should Mention
Chronic hepatitis B requires monitoring, and these signs need urgent attention:
- Jaundice (yellowing of skin and eyes) — may indicate liver decompensation or flare
- Abdominal swelling (ascites) — sign of advanced liver disease
- Unexplained weight loss or fatigue — may indicate progression
- Dark urine with pale stools — suggests liver dysfunction
- Easy bruising or prolonged bleeding — liver may not be producing adequate clotting factors
- Rising ALT levels during monitoring — may indicate immune-active phase requiring treatment initiation
When to Trust AI vs. See a Doctor
AI Is Reasonably Helpful For:
- Understanding what chronic hepatitis B means and how it was acquired
- Learning about the phases of chronic infection and why treatment timing matters
- Understanding transmission risks and the importance of partner vaccination
- Getting general information about liver cancer surveillance
- Learning about lifestyle modifications (alcohol avoidance, medication awareness)
See a Doctor When:
- You have been diagnosed with chronic hepatitis B (ongoing hepatology/gastroenterology care is essential)
- You need regular monitoring of viral load, liver enzymes, and liver imaging
- You need liver cancer surveillance (ultrasound every 6 months)
- Your partner and household contacts need testing and vaccination
- Your viral load or liver enzymes change, potentially indicating a need for treatment
- You develop any symptoms of liver disease
- You are planning pregnancy (mother-to-child transmission prevention is critical)
Methodology
Each AI model received the identical patient scenario prompt. Responses were evaluated by the mdtalks editorial team using our standardized evaluation framework, which assesses factual accuracy against current hepatology guidelines (AASLD), completeness of safety warnings, readability for a general audience, cultural sensitivity, and appropriateness of the recommendation to seek professional care. Scores reflect composite ratings across these dimensions.
Key Takeaways
- Claude 3.5 scored highest (9.1) for its comprehensive explanation of chronic hepatitis B phases and thorough cancer surveillance discussion
- Feeling fine does not mean treatment is unnecessary — monitoring is essential regardless of symptoms
- Partner vaccination is highly effective and should be pursued promptly
- Liver cancer surveillance with twice-yearly ultrasound is a critical component of chronic hepatitis B management
- Gemini scored lowest (7.2) due to oversimplified risk discussion and insufficient treatment information
Next Steps
Learn more about AI’s role in infectious disease and liver health questions:
- Can AI Replace Your Doctor? — why hepatitis B requires ongoing specialist care
- How Accurate Is Medical AI? — AI reliability for viral hepatitis questions
- How to Ask AI Health Questions Safely — getting accurate information about chronic infections
- Compare Medical AI Models — compare AI responses for liver health topics
Published on mdtalks.com | Editorial Team | Last updated: 2026-03-10
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.